Literature DB >> 11900370

Diabetes in sub-Saharan Africa.

T J Aspray1, N Unwin.   

Abstract

NCDs including diabetes, heart disease and stroke are global epidemics of the 21st century. The greatest burden on health will be in developing countries and sub-Saharan Africa is an area of major challenge: We are concerned with planning for the adult victims of the new epidemic and this includes the development of appropriate treatment. Therapy should be cost effective and evidence on the economics of treating chronic conditions in Africa is urgently required. Finally, health promotion, primary prevention and health screening strategies for chronic diseases such as diabetes, stroke and coronary heart disease are required.

Entities:  

Mesh:

Year:  2001        PMID: 11900370     DOI: 10.1007/978-1-4615-1321-6_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia.

Authors:  Mario Azevedo; Sridevi Alla
Journal:  Int J Diabetes Dev Ctries       Date:  2008-10

Review 2.  Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis.

Authors:  Davies Adeloye; Janet O Ige; Adewale V Aderemi; Ngozi Adeleye; Emmanuel O Amoo; Asa Auta; Gbolahan Oni
Journal:  BMJ Open       Date:  2017-05-11       Impact factor: 2.692

3.  Diabetic polyneuropathy with/out neuropathic pain in Mali: A cross-sectional study in two reference diabetes treatment centers in Bamako (Mali), Western Africa.

Authors:  Youssoufa Maiga; Salimata Diallo; Fatoumata Dite Nènè Konipo; Oumar Sangho; Modibo Sangaré; Seybou H Diallo; Saliou Mahamadou; Yann Péréon; Bernard Giumelli; Awa Coulibaly; Mariam Daou; Zoumana Traoré; Djeneba Sow Sylla; Mohamed Albakaye; Cheick Oumar Guinto; Madani Ouologem; Adama S Sissoko; Hamar A Traoré; Souleymane Papa Coulibaly; Philippe Damier; Nadine Attal; Julien Nizard
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.